Works matching IS 00070920 AND DT 2014 AND VI 111 AND IP 10


Results: 19
    1
    2
    3
    4
    5
    6

    The AURORA initiative for metastatic breast cancer.

    Published in:
    British Journal of Cancer, 2014, v. 111, n. 10, p. 1881, doi. 10.1038/bjc.2014.341
    By:
    • Zardavas, D;
    • Piccart, M;
    • Maetens, M;
    • Fumagalli, D;
    • Irrthum, A;
    • Goulioti, T;
    • Engelen, K;
    • Salgado, R;
    • Saini, K S;
    • Aftimos, P;
    • Sotiriou, C;
    • Campbell, P;
    • Dinh, P;
    • von Minckwitz, G;
    • Gelber, R D;
    • Dowsett, M;
    • Di Leo, A;
    • Cameron, D;
    • Baselga, J;
    • Gnant, M
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14
    15

    A parallel-arm phase I trial of the humanised anti-IGF-1R antibody dalotuzumab in combination with the AKT inhibitor MK-2206, the mTOR inhibitor ridaforolimus, or the NOTCH inhibitor MK-0752, in patients with advanced solid tumours.

    Published in:
    British Journal of Cancer, 2014, v. 111, n. 10, p. 1932, doi. 10.1038/bjc.2014.497
    By:
    • Brana, I;
    • Siu, L L;
    • Almhanna, K;
    • Wenham, R M;
    • Gray, J E;
    • Sullivan, D M;
    • Dalton, W S;
    • Berger, R;
    • Golan, T;
    • Haluska, P;
    • Edenfield, J;
    • Stephenson, J;
    • Fiorica, J;
    • Martin, L P;
    • Westin, S;
    • Hanjani, P;
    • Jones, M B;
    • Gunchenko, A;
    • Cheng, J D
    Publication type:
    Article
    16

    HER2/neu testing in primary colorectal carcinoma.

    Published in:
    British Journal of Cancer, 2014, v. 111, n. 10, p. 1977, doi. 10.1038/bjc.2014.483
    By:
    • Ingold Heppner, B;
    • Behrens, H-M;
    • Balschun, K;
    • Haag, J;
    • Krüger, S;
    • Röcken, C;
    • Becker, T
    Publication type:
    Article
    17
    18
    19